Articles about Luke Timmerman

Universal blood test from Microsoft and Adaptive is a Google-sized data challenge

A novel effort from Microsoft and Adaptive Biotechnologies to diagnose multiple diseases from a single blood test is a data… Read More

Podcast

Why this cancer researcher (and survivor) is climbing Kilimanjaro to raise money to study cancer

Kristin Anderson has already fought cancer in more ways than one. She’s a cancer survivor whose battle with breast cancer… Read More

Biotech journalist Luke Timmerman sets his sights on Mount Kilimanjaro and $1M for cancer research

As a journalist, Luke Timmerman has covered biotech for more than 17 years. Now, the Timmerman Report founder is making… Read More

Seattle biotech journalist reaches summit of Mount Everest in bid to raise money for cancer research

Seattle biotech journalist Luke Timmerman reached new heights Tuesday in his efforts to raise awareness for cancer research by successfully… Read More

Podcast

The tipping point on cancer treatment, from research labs to the top of Mount Everest

Luke Timmerman started climbing mountains with college buddies when he was in his 20s. He’s climbed Mount Rainier in Washington… Read More

Why we’re in a ‘different era’ of cancer research, and where things go from here

Four decades ago, the overall chance of someone surviving cancer was about 50-50— not exactly a promising outlook. Today, those… Read More

Biotech journalist Luke Timmerman to climb Mount Everest to raise $175k for cancer research

Biotech journalist Luke Timmerman spends most of his time reading and writing about medical innovation. But now, he’s doing a… Read More

How biotech visionary Leroy Hood redefined the industry: Q&A with biographer Luke Timmerman

In the quest for a better understanding of the human body, the automated DNA sequencer was a breakthrough innovation, giving… Read More

Sneak peek: New biography of biotech pioneer Leroy Hood is revealing and rigorously reported

“Mr. Gates, I Quit.” That’s the opening chapter of “Hood: Trailblazer of the Genomics Age,” and it’s just the first indication… Read More

Veteran biotech journalist Luke Timmerman launches subscription news site

Luke Timmerman, a respected biotechnology journalist known for his past work at The Seattle Times and Xconomy, today launched a new subscription-based biotech news… Read More

Podcast

GeekWire Radio: Amgen and the state of Seattle biotech, with guest Luke Timmerman

Amgen dealt a blow to Seattle’s biotech industry last week with the announcement that it will be closing its large research-and-development campus… Read More

Tech Moves: Microsoft gains activist board member; Ex-Apple VP becomes first female director at GoDaddy; etc.

—Mason Morfit, president of ValueAct Capital, has joined Microsoft’s board and will also serve on the board’s audit committee. Morfit’s appointment is part… Read More